Armando Lucero-Acuña

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Molecularly Imprinted

Pulmonary Tuberculosis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Karol Yesenia Hernández-Giottonini, Beatriz Arellano-Reynoso, Rosalva Josefina Rodríguez-Córdova, Jonathan de la Vega-Olivas, Efrén Díaz-Aparicio, Armando Lucero-Acuña
Enhancing Therapeutic Efficacy against Brucella canis Infection in a Murine Model Using Rifampicin-Loaded PLGA Nanoparticles. ACS omega 8 (51) (2023)
Karol Yesenia Hernández-Giottonini, Beatriz Arellano-Reynoso, Rosalva Josefina Rodríguez-Córdova, Jonathan de la Vega-Olivas, Efrén Díaz-Aparicio, Armando Lucero-Acuña
Enhancing Therapeutic Efficacy against Brucella canis Infection in a Murine Model Using Rifampicin-Loaded PLGA Nanoparticles. ACS omega 8 (51) (2023)
Omar Peñuñuri-Miranda, Miguel Olivas-Martinez, José Alberto Ibarra-Espinoza, Rosalva Josefina Rodríguez-Córdova, Karol Yesenia Hernández-Giottonini, Daniel Fernández-Quiroz, Paul Zavala-Rivera, Armando Lucero-Acuña
Spatiotemporal Temperature Distribution of NIR Irradiated Polypyrrole Nanoparticles and Effects of pH. Polymers 14 (15) (2022)
Marco Vizcarra-Pacheco, María Ley-Flores, Ana Mizrahim Matrecitos-Burruel, Ricardo López-Esparza, Daniel Fernández-Quiroz, Armando Lucero-Acuña, Paul Zavala-Rivera
Synthesis and Characterization of a Bioconjugate Based on Oleic Acid and L-Cysteine. Polymers 13 (11) (2021)
Karol Yesenia Hernández-Giottonini, Rosalva Josefina Rodríguez-Córdova, Cindy Alejandra Gutiérrez-Valenzuela, Omar Peñuñuri-Miranda, Paul Zavala-Rivera, Patricia Guerrero-Germán, Armando Lucero-Acuña
PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters. RSC advances 10 (8) (2020)
Armando Lucero-Acuña, Cindy Alejandra Gutiérrez-Valenzuela, Reynaldo Esquivel, Roberto Guzmán-Zamudio
Mathematical modeling and parametrical analysis of the temperature dependency of control drug release from biodegradable nanoparticles. RSC advances 9 (16) (2019)